KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Exchange Rate Effect (2017 - 2025)

Fulgent Genetics (FLGT) has disclosed Exchange Rate Effect for 9 consecutive years, with $75000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 155.97% to $75000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105000.0 through Dec 2025, up 290.91% year-over-year, with the annual reading at $105000.0 for FY2025, 290.91% up from the prior year.
  • Exchange Rate Effect hit $75000.0 in Q4 2025 for Fulgent Genetics, up from $15000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $387000.0 in Q3 2022 to a low of -$571000.0 in Q2 2022.
  • Historically, Exchange Rate Effect has averaged -$28833.3 across 5 years, with a median of $7000.0 in 2022.
  • Biggest YoY gain for Exchange Rate Effect was 13000.0% in 2022; the steepest drop was 875.0% in 2022.
  • Year by year, Exchange Rate Effect stood at $36000.0 in 2021, then tumbled by 875.0% to -$279000.0 in 2022, then soared by 151.97% to $145000.0 in 2023, then plummeted by 192.41% to -$134000.0 in 2024, then skyrocketed by 155.97% to $75000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for FLGT at $75000.0 in Q4 2025, $15000.0 in Q3 2025, and $4000.0 in Q2 2025.